Publisher
Archives of Endocrinology and Metabolism
Subject
Endocrinology, Diabetes and Metabolism
Reference41 articles.
1. SGLT2 inhibitors: a new emerging therapeutic class in the treatment of type 2 diabetes mellitus;Ghosh;J Clin Pharmacol,2012
2. Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus;Komoroski;Clin Pharmacol Ther,2009
3. Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes;List;Diabetes Care,2009
4. Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial;Lavalle-González;Diabetologia,2013
5. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial;Ferrannini;Diabetes Care,2010
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献